Table 1.
Characteristics of study subjects
| Variable | Control (n=26) | NAFLD (n=27) | p |
|---|---|---|---|
|
| |||
| Age (years) | 40.5±12.4 | 43.1±10.3 | ns |
| Female, n (%) | 25 (96) | 24 (89) | ns |
| BMI (kg/m2) | 48.8±5.9 | 49.6±7.4 | ns |
| Diabetes, n (%) | 7 (26.9) | 11 (40.7) | ns |
| Hypertension, n (%) | 13 (50) | 19 (70.3) | ns |
| Fasting glucose (mg/dL) | 103.9±43.2 | 131.0±50.8 | 0.04 |
| Fasting insulin (mu/mL) | 20.2±13.5 | 35.8±20.0 | 0.001 |
| Total cholesterol (mg/dL) | 175.8±29.1 | 178.3±38.6 | ns |
| Triglycerides (mg/dL) | 123.6±37.3 | 172.9±80.3 | 0.006 |
| HDL (mg/dL) | 45.4±9.1 | 41.1±7.9 | ns |
| LDL (mg/dL) | 105.5±26.2 | 103.3±32.2 | ns |
| ALT (U/L) | 18.1±11.6 | 30.0±16.3 | 0.003 |
| Total bilirubin (mg/dL) | 0.4±0.1 | 0.5±0.3 | ns |
| Alkaline phosphatase (U/L) | 74.3±31.1 | 73.3±23.2 | ns |
| Platelets (103/uL) | 309.3±73.6 | 298.9±72.7 | ns |
Data presented as frequency or mean ± standard deviation unless otherwise indicated